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Finely tuned regulation of epithelial cell death maintains tissue integrity and homeostasis. At the cellular level, life and 
death decisions are controlled by environmental stimuli such as the activation of death receptors. We show that cell polarity 
and adherens junction formation prevent proapoptotic signals emanating from the Fas death receptor. Fas is sequestered in 
E-cadherin actin-based adhesion structures that are less able to induce downstream apoptosis signaling. Using a proteomic-
based approach, we find that the polarity molecule Dlg1 interacts with the C-terminal PDZ-binding site in Fas and that this 
interaction decreases formation of the death-inducing complex upon engagement with Fas ligand (FasL), thus acting as an 
additional cell death protection mechanism. We propose that E-cadherin and Dlg1 inhibit FasL-induced cell death by two 
complementary but partially independent mechanisms that help to maintain epithelial homeostasis by protecting normal 
polarized epithelia from apoptosis. When polarity is lost, the Fas–cadherin–Dlg1 antiapoptotic complex is disrupted, and FasL 
can promote the elimination of compromised nonpolarized cells.
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Introduction
Programmed cell death by apoptosis is a physiological process 
that leads to the elimination of damaged or potentially harmful 
cells to maintain tissue homeostasis. As a consequence, evad-
ing apoptosis is an integral part of tumor development and re-
sistance to therapy (Hanahan and Weinberg, 2011). Cytokines 
of the TNF receptor family including the Fas receptor (CD95; 
TNF RSF6) are among the best-characterized apoptosis inducers. 
The apoptotic signaling induced by Fas upon activation by its li-
gand (FasL; TNF SF6) depends on the recruitment to the recep-
tor of adaptor proteins and caspases forming a death-inducing 
signaling complex (DISC). This complex triggers caspase activa-
tion, responsible for the proteolytic cleavage of a broad spectrum 
of cellular targets, leading ultimately to cell death (Kischkel et 
al., 1995). Beside this prodeath function, Fas activation can also 
promote alternative nondeath signaling pathways leading to cell 
survival, proliferation, motility, cancer growth, and metastasis, 
depending on the cellular context (Peter et al., 2007). Invalida-
tion and mutations of the Fas/FasL system in animal models and 
in human pathologies mainly demonstrate that Fas regulates tis-
sue homeostasis in the immune system through the induction 
of apoptosis (Ramaswamy et al., 2009). Nevertheless, previous 
work reports that Fas is expressed in almost all human tissues 
including many epithelia such as the intestine (Chen et al., 2010). 
Therefore activation of Fas in these tissues has to be strictly con-
trolled in order to maintain an equilibrium between survival and 
cell death signals.
At a cellular level, the life-and-death decision is controlled by 
different environmental cues including cell anchorage, which 
guarantees both cell–ECM adhesion and cell–cell adhesion thanks 
to different sets of specialized macrocomplexes. Both types of ad-
hesion complexes have been shown to protect from cell death, 
but the exact mechanisms underlying these observations are still 
debated (Grossmann, 2002; Stupack and Cheresh, 2002). Cell–
cell contacts are mediated by specialized cell surface receptors 
including E-cadherin, the main cell–cell adhesion molecule ex-
pressed in epithelial tissues. The cytosolic domain of E-cadherin 
interacts with catenins (α-, β-, and p-120), which are adaptor 
molecules that connect the receptor to the actin cytoskeleton to 
form intercellular adhesion complexes called adherens junctions 
(AJs; Niessen et al., 2011). AJs play a master organizer role in the 
establishment of apical–basal polarity and are found functionally 
associated with the Scrib–Dlg1–Hugl1 polarity complex (Reuver 
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and Garner, 1998; Qin et al., 2005). In addition, AJs act as signal-
ing platforms and are directly involved in the control of various 
pathways (Kobielak and Fuchs, 2006; McCrea et al., 2015). Their 
signaling capacities are at least in part due to their ability to as-
sociate with some cell surface receptors and to modulate their 
activities (Qian et al., 2004; Curto et al., 2007; Fukuhara et al., 
2008; Lu et al., 2014). Alteration of AJs in epithelia is associated 
with loss of cell–cell contacts and cell polarity, which leads to 
uncontrolled proliferation and carcinoma formation (Jeanes et 
al., 2008; Stairs et al., 2011). However, loss of AJs in various an-
imal models or in in vitro studies has been also associated with 
increased cell death (Carmeliet et al., 1999; Hofmann et al., 2007; 
Schneider et al., 2010), which is in agreement with a role of cell–
cell junctions in the regulation of cell survival.
The possible role of cell–cell contacts and cell polarity in the 
control of Fas signaling has been largely unexplored. In this 
study, we report that E-cadherin plays a critical role in the regu-
lation of Fas cell death signaling. Indeed, we demonstrate that in 
polarized colon epithelial cells, Fas is sequestered in E-cadherin 
actin-based adhesion structures, preventing its cell death sig-
naling function. Moreover, we identify that the C-terminal PDZ 
domain of Fas interacts with the polarity molecule Dlg1, which 
accumulates together with AJs at cell–cell junctions. The interac-
tion of Dlg1 with Fas inhibits Fas cell death signaling by impairing 
efficient formation of the DISC. Therefore, our findings uncover 
an important mechanistic link between cell–cell contacts and cell 
polarity along with the protection of polarized cohesive epithelial 
tissues from the Fas-induced death signal.
Results and discussion
Cell–cell contacts protect epithelial colon cells from FasL-
induced cell death
To evaluate the importance of human epithelial tissue organiza-
tion, and in particular cell–cell junctions, in the regulation of Fas 
proapoptotic signaling, we first analyzed the FasL-induced sensi-
tivity of HCT15 cells, a human epithelial cell line of colon origin, 
which forms extensive cell–cell junctions and grows as indepen-
dent islets (Fig. 1 A). Using time-lapse video microscopy experi-
ments, we showed that induction of cell death by addition of FasL 
in HCT15 cells occurs preferentially in the cells located in the islet 
periphery that do not form mature junctions or in cells that do not 
form a cohesive islet (Fig. 1 A and Video 1). In contrast, cells that 
form extensive cell–cell junctions (i.e., located in the center of the 
islet) are protected from cell death. Treatment of HCT15 with stau-
rosporine, a widely used chemical promotor of intracellular stress 
apoptosis, did not reveal a protective effect of cell–cell junctions 
(Fig. 1 A and Video 2), suggesting that cell–cell contacts specifically 
affect Fas signaling rather than having a general antiapoptotic ef-
fect. To rule out the possibility that the cell death resistance of cells 
located in the center of the islet was due to a limited diffusion of 
FasL through tight junction assembly, HCT15 cells were grown on 
permeable culture inserts. Video microscopy experiments showed 
that FasL treatment in both apical and basal reservoirs did not sen-
sitize the central cells of the islet to FasL, demonstrating that this 
protective effect cannot be explained by a restriction of FasL dif-
fusion at the basal side of the cells (Video 3).
Since maturation of cell–cell contacts including tight junc-
tions and AJs requires the presence of extracellular calcium 
(Takeichi, 1988), we then analyzed the FasL-mediated cell death 
induction in HCT15 cells in which cell junctions were disrupted 
by growing cells in low-calcium conditions (Fig. 1 A and Video 4). 
Depletion of calcium resulted in a strong increase of FasL-induced 
cell death (Fig. 1, B–D and I), confirming the protective effect of 
cell–cell contacts in the regulation of Fas proapoptotic signaling.
To further characterize the nature of the cell–cell adhesion 
complex involved in the regulation of Fas signaling, we evaluated 
the role of AJs, the major cell–cell contact organizers (Halbleib 
and Nelson, 2006; Niessen et al., 2011), by specifically targeting 
their assembly. This was achieved by the transfection of HCT15 
cells with siRNAs directed against either α-catenin, which is 
essential to nucleate mature AJs (Vasioukhin et al., 2001), or 
E-cadherin. We showed that the partial knockdown of AJ com-
ponents alters cell–cell contact formation and results in a strong 
increase in the number of cells sensitive to FasL-mediated cell 
death (Fig. 1, E–H and J). Altogether, these experiments suggest 
that the formation of AJs in human epithelial cells inhibits the 
proapoptotic function of the Fas receptor.
Fas associates and forms a stable complex with AJs
Since the formation of AJs regulates Fas cell death signaling, we 
analyzed the localization of Fas at the border and the center of the 
cell islets. We found that at cell–cell contacts of confluent cells, Fas 
strongly colocalizes with E-cadherin (Fig. 2, A–C) and α-catenin 
(Fig. 2 F; Pearson coefficient of 0.815 and 0.655 for E-cadherin 
and α-catenin, respectively). Fas colocalized with E-cadherin to-
gether with actin in the zona adherens located at the apical end 
of lateral cell–cell contacts (Fig. 2, A and B, arrows) but also in 
cell contacts formed along the lateral surface of HCT15 epithelial 
cells (Fig. 2 B, arrowheads). Interestingly, Fas was less enriched 
in AJs in cells located at the periphery of the islet (Fig. 2, A and 
D), suggesting that maturation of cell–cell contacts favors Fas–E-
cadherin association. Using proximity ligation assays (PLAs), we 
confirmed the molecular proximity of Fas and AJ components in 
HCT15 cells (Fig. 2 E). A similar colocalization of Fas and AJs was 
observed in human colon epithelial tissues, showing that Fas un-
dergoes a similar polarized expression in vivo (Fig. 2 G).
To finely evaluate the role of AJs in the polarized expression of 
the Fas receptor, its localization was analyzed by immunofluores-
cence (IF) in HCT15, in which cell–cell contacts were disrupted by 
inhibiting α-catenin expression with siRNA. As shown in Fig. 2 F, 
in the absence of cell–cell junctions, Fas is no longer limited to 
a specific domain of the plasma membrane but rather becomes 
expressed all over the plasma membrane.
The formation of mature AJs corresponds with the assembly 
of cadherins and various cytoplasmic molecules together with 
the actin cytoskeleton into a macromolecular complex charac-
terized by its detergent insolubility (Kinch et al., 1995). Since 
Fas associates with AJs in confluent cells, we analyzed whether 
the detergent solubility of Fas was dependent on AJ formation. 
Detergent solubility assays demonstrated that the proportion of 
Fas molecules associated with the detergent-insoluble cytoskel-
etal fraction decreased in HCT15 cells transfected with either 
α-catenin or E-cadherin siRNAs compared with cells transfected 
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Figure 1. AJs protect epithelial colon cells from FasL-induced cell death. (A) HCT15 cells were grown in normal media or in low-calcium conditions 
(20 µM) before FasL (20 ng/ml + M2) or staurosporine (20 µM) treatment. Cell death was analyzed by phase-contrast time-lapse microscopy. Arrows indicate 
the localization of dead cells. Bar, 50 µm. (B–D) HCT15 cells were grown in media containing various concentrations of calcium (from 1,800 µM [normal 
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with a control siRNA (Fig. 2, H and I). Altogether, our data sug-
gest that maturation of AJs controls the presence of Fas at sites 
of cell–cell contacts and its molecular association with this 
adhesion complex.
Sequestration of Fas in AJs inhibits FasL binding to the plasma 
membrane and consequently cell death signaling
To determine whether the inhibition of FasL-mediated cell death 
signaling found in confluent cells was due to a less-efficient bind-
ing of FasL to the cell surface, we developed a FasL-binding assay 
using FasL-coated beads. FasL-coated beads and noncoated beads 
were added to HCT15 cells forming mature cell–cell contacts or in 
which AJs were disrupted by transfecting cells with an α-catenin 
siRNA. Following 30 min incubation, FasL binding efficiency was 
determined using microscopic observations, bead counting, and 
IF studies (Fig. 3, A–E).
We showed that FasL-coated beads bound efficiently to HCT15 
cells compared with noncoated control beads (Fig. 3 B). More-
over, IF studies followed by quantitative analyses revealed that 
FasL-coated beads induced a progressive accumulation of Fas and 
caspase-8 to small patches located beneath the area of bead–cell 
contacts (Fig. 3, C–E). As expected, a longer activation time (90 
min) led to a strong cytosolic accumulation of activated caspase-8 
associated with cell shrinkage (Fig. 3 C). Fas and caspase-8 re-
cruitments were mostly observed beneath the beads attached to 
cells located at the border of the islet, suggesting that the effi-
ciency of FasL binding is improved in bordering cells in which 
Fas does not accumulates in AJs. We next used the same FasL-
coated bead assay to isolate Fas receptors together with DISC 
components. In agreement with our IF results, the quantity of 
Fas immunoprecipitated at each time point strongly increases 
during activation time, suggesting that the aggregation of Fas 
underneath each bead is a dynamic process (Fig. 3 F). These re-
sults demonstrated that FasL-coated beads preferentially bind to 
epithelial cells located at the margin of the islet, which do not 
form extensive cell–cell junctions.
We then compared the FasL-coated bead-binding efficiency 
and the caspase activation of HCT15 cells in which AJs were dis-
rupted by knocking down α-catenin expression using specific 
siRNA. In the absence of AJs, FasL-coated beads were able to bind 
efficiently to the cells within the islet independently of their po-
sition and not only to the cells located at the periphery (Fig. 3 A), 
suggesting that the absence of AJs sensitizes cells within the 
islet to FasL binding. Counting the beads bound in each culture 
condition confirmed that the absence of AJs strikingly increased 
the binding efficiency of FasL-coated beads compared with con-
trol cells (siCtrl; Fig. 3 B). In agreement with these observations, 
more DISC components (Fas, caspase-8, and FADD) were pulled 
down by FasL-coated beads in α-catenin–knockdown cells com-
pared with control cells (Fig. 3, F and G). Altogether, our results 
demonstrate that the disruption of AJs increases the availability 
of the Fas receptor for ligand binding, which strongly increases 
epithelial cell sensitivity to FasL-induced cell death.
The Fas C-terminal PDZ binding site interacts with various 
PDZ proteins and is required to stabilize and localize Fas at 
cell–cell contact
Recent examples demonstrate that PDZ domain–containing 
molecules interact directly with various cell surface receptors 
through a PDZ-binding site to target them to specific membrane 
domains including cell–cell contacts (Borg et al., 2000; Curto et 
al., 2007; Theisen et al., 2007; Chiasson-MacKenzie et al., 2015). 
Since Fas has been reported to contain a PDZ C-terminal bind-
ing motif (Yanagisawa et al., 1997), we tested the possibility that 
this domain was involved in the subcellular localization of Fas 
at cell–cell contacts. We generated HCT15 cells stably express-
ing a GFP-tagged version of the WT or a mutant form of Fas in 
which the last three amino acids (SLV), which compose a class I 
PDZ-binding motif (FasGFPΔSLV), were deleted (Fig. 4 A). Con-
focal analysis of the subcellular distribution of the FasGFP WT 
and FasGFPΔSLV ectopic receptors was performed on HCT15 
cells stably expressing these constructs and forming extensive 
cell–cell junctions. This experiment showed that whereas FasGFP 
WT mainly colocalizes with E-cadherin at the lateral cell–cell 
junctions, FasGFPΔSLV not only does not efficiently associate 
with cell–cell junctions but also displays a cytosolic localization 
(Fig. 4, B and C). Cell surface biotinylation assays confirmed that 
the FasGFPΔSLV mutant is significantly less expressed at the 
cell surface compared with the WT form of Fas (Fig. 4, D and E). 
Detergent solubility assays demonstrated that the FasGFPΔSLV 
mutant is more soluble than its WT counterpart (Fig. S1 A), which 
correlates with a reduced association of the Fas PDZ mutant to 
cell–cell junctions. Thus, these data suggest that the Fas C-termi-
nal PDZ binding site is required to target and/or to sequester Fas 
at cell–cell junctions.
We then used a previously described proteomic approach 
(Belotti et al., 2013) to identify the Fas molecular partner(s) able 
to associate with the PDZ-binding site of Fas and possibly be in-
volved in its subcellular localization. Two peptides correspond-
ing respectively with the last 20 amino acids of WT Fas and a 
mutant form lacking the PDZ-binding motif (FasΔSLV; Fig. 4 A) 
were bound to agarose beads and used as baits to pull down Fas 
molecular partners from HCT15 cell extracts. Following pull-
down experiments, proteomic analysis allowed us to identify 53 
molecules that were significantly pulled down with the FasWT 
peptide but not with the Fas peptide lacking the PDZ-binding 
motif (Fig. 4 F and Table S1). Among these proteins, 19 are PDZ 
domain–containing proteins, which have been associated with 
conditions] to 20 µM [low conditions]) before FasL treatment (15 ng/ml + M2), and cell death was measured by monitoring caspase-8 activation (presence 
of p43/41 and p30 cleaved fragments) and PARP cleavage by IB. Relative caspase-8 activation (p41/43) and PARP cleavage were measured by quantitative 
densitometry (n = 3). (E–G) Cell death was induced by FasL treatment (15 ng/ml + M2) in HCT15 cells transfected with the indicated siRNAs and analyzed 
by IB as above. IBs were quantified by densitometry (n = 3). (H) The efficiency of each siRNA was verified by IB. (I and J) Cell death was analyzed by sub-G1 
quantification (PI incorporation) in HCT15 grown in low-calcium conditions or transfected by the indicated siRNAs. Arrowheads in B and E indicate the 
cleaved forms of PARP. In all graphs, error bars represent means ± SEM. *, P < 0.05; **, P < 0.01; Student’s t test.
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Figure 2. Fas accumulates at cell–cell junctions and colocalizes with AJ components in both colorectal cell lines and colon tissue sections. (A) Detec-
tion of E-cadherin, actin, and Fas by IF on HCT15 cells in border or center regions of the cell islet. An enlarged part of images from bordering cells is shown. 
Arrows indicate the diffuse localization of Fas at the plasma membrane in bordering cells. (B) XZ projection of Z stack acquired in A. Arrows and arrowheads 
indicate Fas–E-cadherin colocalization both at the zona adherens and along the lateral surface, respectively. (C) Line scan (yellow line in A) profile of fluores-
cence intensity of Fas, E-cadherin, and actin obtained at the center of the cell islet. (D) Quantification of the specific enrichment of Fas at cell–cell junctions 
in cells located at the center (confluent area) compared with the border of the HCT15 cell islets. Bars in graphs represent means ± SEM (n = 5). (E) PLA was 
used to determine the interaction of Fas and E-cadherin in HCT15 cells. Red fluorescent spots indicate colocalization of Fas and E-cadherin. PLA dots/cells in 
each condition were counted, and the right panel shows the mean of dots/cells ± SEM. One representative experiment is shown out of three. (F) Detection of 
Fas and α-catenin in HCT15 invalidated for α-catenin expression by using an siRNA approach. A XZ projection of Z stack is shown. (G) IF localization of Fas and 
E-cadherin in human colon tissue sections using confocal microscopy. (H and I) Fas detergent solubility in HCT15 cells transfected by the indicated siRNAs 
was analyzed by IB. S, soluble fraction; I, insoluble cytoskeletal fraction. Erk-2 and caveolin-1 were used as controls of soluble protein and membrane protein, 
respectively. Relative percentage of solubility of Fas in each condition was quantified by densitometry (n = 3). Bars in graphs represent means ± SEM (n = 5). 
Bars: 10 µM (A, B, E, and F); 20 µM (G). *, P < 0.05; Student’s t test.
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Figure 3. AJs sequester Fas at site of cell–cell junction, and this impairs efficient FasL binding and therefore Fas cell death signaling. (A) Binding assays 
of latex beads coated with FasL (Beads FasL) on HCT15 transfected with siRNAs against α-catenin and followed by phase-contrast microscopy. (B) FasL-coated 
or -noncoated (NC) beads attached to cells were counted using flow cytometry after cell lysis. Graphs represent means ± SEM (n = 3). (C and D) Detection of 
Fas and cleaved caspase-8 in HCT15 cells incubated with FasL-coated beads was done by IF at different time points. Beads appear in red (by autofluorescence). 
An XZ projection of the Z stack is shown. Arrows indicate the accumulation of Fas beneath the beads. (E) Accumulation of Fas and activated caspase-8 under 
FasL-coated beads was quantified. Graph represents mean ± SEM (n > 3). (F) FasL-coated beads were used to immunoprecipitate activated Fas from cell lysates 
of HCT15 cells transfected with indicated siRNAs. Fas, caspase-8, and FADD were detected by IB. Arrows and arrowheads indicate native caspase-8 and cleaved 
(activated) caspase-8, respectively. (G) Relative caspase-8 and Fas were quantified by densitometry at t = 0 or after 30 min FasL-coated bead activation (n = 
3). Bars: 10 µM (C and D); 50 µM (A). *, P < 0.05; **, P < 0.01; Student’s t test.
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Figure 4. Fas PDZ binding domain regulates Fas cell–cell junction localization and interacts with the polarity molecule Dlg1. (A) Schematic represen-
tation of human Fas constructs and of the C-terminal sequence of Fas. The SLV C-terminal PDZ-binding motif is shown in red. TM, transmembrane domain. 
(B) Detection of E-cadherin and GFP by IF in HCT15 cells transduced with empty vector (EV), GFP-Fas WT, and ΔSLV mutant. (C) Quantification of the specific 
enrichment of GFP-Fas WT and ΔSLV mutant at cell–cell junctions. Error bars in graphs represent means ± SEM (n = 5). (D) Cell surface expression of GFP-Fas 
WT and ΔSLV mutant were compared using biotinylation assays. (E) Relative cell surface expression of GFP-Fas WT and of the ΔSLV mutant was quantified 
by densitometry. Error bars in graphs represent means ± SEM (n = 3). (F) Volcano plot summarizing comparison between the protein interacting with Fas 
C-terminal (Cter) peptide of WT and the ΔSLV mutant. The log2 ratio of protein intensities was plotted against negative log10 P values. Red circles correspond 
with proteins significantly more abundant in the WT than in the ΔSLV mutant (P < 0.05), and blue circles correspond with proteins without significant changes. 
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cell–cell junctions, cell polarity, receptor trafficking, and actin 
cytoskeleton interaction/regulation. FAP1 is the only protein al-
ready identified as a Fas interactor (Yanagisawa et al., 1997).
The most abundant protein found to interact with the Fas 
C-terminal part is the polarity molecule Dlg1. Dlg1 is a scaffold 
molecule containing four PDZ domains, and it belongs to the 
Scrib polarity complex. Dlg1 has been found to be tightly associ-
ated with AJs in various animal and cellular models (Reuver and 
Garner, 1998; Guo et al., 2014). Moreover, Dlg1 has been found to 
interact with several molecular partners also identified in our 
proteomic analysis such as CASK, Lin7c, and MPP7 (Fig. 4 F). Pull-
down experiments followed by immunoblotting (IB) were used 
to verify the interaction of the Fas C-terminal domain with Dlg1 
as well as with other abundant PDZ domain–containing proteins 
identified in our screen such as CASK, Lin7c, SNTB2, and PATJ 
but not with NHE RF1, used as a negative control (Fig. 4 G). Using 
pulldown experiments, we also showed that the knockdown of 
Dlg1 expression by siRNAs affects the recruitment of several Fas 
molecular partners known to associate with Dlg1, such as CASK 
and Lin7c, but has only a minor effect on other PDZ-binding 
proteins (Fig. 4, H and I), supporting the idea that Dlg1 could or-
ganize a complex structural network composed of several pro-
teins linked to the Fas C-terminal domain and connected to the 
actin cytoskeleton.
To further demonstrate the molecular interaction between 
Fas and Dlg1, Fas–Dlg1 association was verified by using both 
Fas immunoprecipitation (IP) experiments in 293T cells tran-
siently transfected with Dlg1 and various Fas-deletion mutants 
(Fig. S1 B) as well as PLA on HCT15 cells (Fig. 5 D). Our results 
support the idea of a direct interaction between Fas and Dlg1 in 
epithelial cells.
The Dlg1 polarity molecule colocalizes with Fas and inhibits 
FasL-induced cell death signaling
As we mentioned, the Dlg1 polarity molecule has been found 
tightly associated with E-cadherin (Guo et al., 2014). As expected, 
IF experiments demonstrate that Dlg1 colocalizes with Fas at 
cell–cell junctions (Pearson’s correlation coefficient of 0.73) in 
HCT15 cells, both at the border and in the center of the cell islets 
(Fig. 5, A and B).
We then investigated the importance of the Fas–Dlg1 asso-
ciation on Fas plasma membrane stability, localization, and 
signaling using a loss-of-function approach. IF experiments 
demonstrated that the knockdown of Dlg1 in HCT15 cells only 
slightly impacts Fas localization at the cell junctions (Fig. 5, A 
and C). In agreement with this result, solubilization assays re-
vealed that siRNA silencing of Dlg1 in HCT15 has only a modest 
effect on Fas and α-catenin solubility (Fig. S2 A), suggesting that 
in HCT15 cells, AJ formation and Fas recruitment in AJs do not 
absolutely require Dlg1.
We then compared the binding efficiency of FasL-coated 
beads on HCT15 cells in which Dlg1 expression was knocked 
down by siRNAs. Dlg1 silencing in HCT15 did not statistically 
modify either the binding efficiency of FasL-coated beads or the 
preferential binding on peripheral cells observed in control cells 
(Figs. 3 A and S2 B). This suggests that the absence of Dlg1 is not 
sufficient to affect the Fas basal–lateral localization and to sensi-
tize cells within islets to FasL binding as it occurs when cell–cell 
junctions are disrupted.
The potential role of Dlg1 in the modulation of Fas proapop-
totic signaling was then studied by comparing FasL death sensi-
tivity of HCT15 cells transfected with either control (siCtrl) or 
two different Dlg1 (siDlg1#1 and 2) siRNAs. The knockdown of 
Dlg1 significantly increased Fas-induced cell death as judged by 
IB using anti–cleaved caspase-8 and poly-ADP ribose polymerase 
(PARP) antibodies (Fig. 5, E and F). The increase of Fas cell death 
correlates with a slight increase of Fas total and cell surface ex-
pression in cells transfected by siRNAs against Dlg1 compared 
with a control receiving the control siRNA (siCtrl; Fig. S2 C). 
To analyze whether the role of Dlg1 in the regulation of Fas cell 
death signaling was dependent on AJ formation, we took advan-
tage of another colorectal cell line named SW480 that does not 
form AJs due to a very low level of E-cadherin expression (Fig. 
S2 D; Conacci-Sorrell et al., 2003). The absence of Dlg1 in SW480 
cells strongly increased FasL-induced cell death (Fig. 5, E and F) 
without significantly affecting Fas total or cell surface expres-
sion (Fig. S2 E).
Altogether, these data show that Dlg1 does not play an essen-
tial role in the sequestration of Fas in AJs but inhibits Fas cell 
death signaling by modulating the ability to optimally form a 
DISC upon FasL engagement. Since the Fas PDZ mutant is un-
able to efficiently localize in AJs, we hypothesize that other PDZ 
molecules may participate or compensate for the absence of Dlg1 
to target/stabilize Fas at cell–cell junctions. Indeed, several PDZ 
proteins identified in our screen, such as MAGI-1/3, β2-syntro-
phin, MPP7, and CASK, have been found associated with cell–cell 
junctions. Further studies would be necessary to determine the 
exact mechanism by which Dlg1 interferes with cell death signal-
ing. Indeed, several examples have shown that Dlg1 modulates 
receptor signaling by influencing their trafficking, localization, 
and molecular environment by recruiting adaptor molecules 
(Round et al., 2005; Fourie et al., 2014).
In this study, we uncover a new role of AJs as key regulators 
of Fas proapoptotic signaling in polarized epithelial cells. We 
clearly demonstrate that AJ formation is accompanied by the 
accumulation of Fas receptor within these adhesion complexes. 
This results in a strong inhibition of Fas-mediated cell death by 
impairing efficient FasL binding, thereby preventing the activa-
tion of the receptor. Moreover, we unravel that Fas accumula-
tion in these lateral cellular domains requires the PDZ-binding 
domain of Fas. Using a proteomics approach, we reveal that this 
domain of Fas interacts preferentially with Dlg1, a scaffold mole-
cule involved in the maintenance of cell polarity. We demonstrate 
that the Fas–Dlg1 interaction inhibits Fas cell death signaling, 
(G) Pulldown experiment done with the C-terminal peptide of Fas (WT or FasΔSLV) followed by IB. (H) Pulldown experiment done with beads coupled to the 
C-terminal peptide of WT Fas on cell lysates of HCT15 transfected with the indicated siRNAs and followed by IB. (I) Relative expression of each protein pulldown 
with WT Fas C-terminal peptide was quantified by densitometry (n = 3). Bars, 10 µM. *, P < 0.05; Student’s t test.
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Figure 5. Dlg1 is an inhibitor of Fas cell death signaling. (A) Detection of Fas and Dlg1 by IF in control and Dlg1-knockdown HCT15 cells. (B) Line scan profile 
(yellow line in A) of fluorescence intensity of Fas, Dlg1, and actin in confluent cells. (C) Quantification of the specific enrichment of Fas at cell–cell junctions in 
control and Dlg1-knockdown HCT15 cells. Error bars in graphs represent means ± SEM (n = 5). (D) PLA was used to determine the interaction of Fas and Dlg1 
in HCT15 cells as in Fig. 2 E. PLA dots/cells in each condition were counted, and the right panel shows the mean of dots/cells ± SEM. One representative exper-
iment is shown (n = 3). (E and F) Cell death induced by FasL (15 ng/ml + M2) in HCT15 and SW480 cells transfected with the indicated siRNAs was analyzed 
as described above. Relative caspase-8 activation (p41/43) and PARP cleavage were quantified by densitometry (n = 3). (G) Schematic model summarizing the 
inhibitory function of E-cadherin and Dlg1 on Fas pro–cell death signaling. *, P < 0.05; Student’s t test.
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suggesting that Dlg1 interferes with the formation/stability of 
the death signaling complex. Therefore, accumulation of Fas at 
cell–cell junctions inhibits Fas cell death signaling by at least two 
different complementary mechanisms (Fig. 5 G).
Our study supports for the first time in human cells a molec-
ular link between a scaffold protein involved in the maintenance 
of cell polarity and a cell death receptor. This result is in agree-
ment with previous studies revealing the importance of cell po-
larity in the control of cell death (Weaver et al., 2002; Brumby 
and Richardson, 2003; Igaki et al., 2009; Frank et al., 2012). This 
cell death–regulatory mechanism is crucial to protect normal cells 
from apoptotic signals and to sense and eliminate abnormal cells 
from epithelial tissues in pathological conditions such as tumor 
development. Our data reveal a striking similarity with data 
obtained in Drosophila melanogaster in which activation of the 
fly TNF receptor Grnd by its ligand Eiger leads to the apoptotic 
elimination of mispolarized clonal epithelial cells due to siRNA 
silencing of Scrib or Dlg1 (Igaki et al., 2009; Andersen et al., 2015). 
Moreover, Gnrd is found associated with the Crumbs polarity com-
plex and Veli (lin7), which regulates the fly TNF receptor signaling 
capacity. Our proteomics analysis demonstrates that Lin7c, the 
mammalian homologue of Veli, also interacts with Fas and that 
its association with Fas is dependent on Dlg1, suggesting that the 
control of TNF receptor signaling by polarity molecules has been 
conserved during evolution.
Finally, since Fas activation also leads to nonapoptotic signal-
ing, in particular in the context of tumor development (Peter et 
al., 2007), it is possible that recruitment of Dlg1 and/or E-cad-
herin by Fas blocks cell death signaling while alternatively 
promoting nondeath pathways. Therefore, our study opens the 
door for further investigations to unravel the molecular mecha-
nisms underlying the versatile regulation of Fas signaling by the 
cadherin–Dlg1 complex.
Materials and methods
Reagents and antibodies
For IB or IF, antibodies against anti-Fas (B10), Dlg1/SAP97 (2D11 
and S19), Erk-2, Lin7 (C15), and CASK (H107) were purchased from 
Santa Cruz Biotechnology; anti–caspase-8 and Fadd were from 
MBL; anti–cleaved caspase-8 (cl. caspase-8) and PARP were from 
Cell Signaling Technology; anti–caspase-10 was from BioVision; 
anti–β-catenin, N-cadherin, and NHE RF1 were from BD; anti-HA 
was from Covance; anti–E-cadherin was from Invitrogen; anti-Fas 
(EPR5700), p120, E-cadherin, and α-catenin were from Epitomics; 
anti-GAP DH was from EMD Millipore; anti-PATJ was from Gene-
Tex; and anti–β2-syntrophin (SNTB2) was from Thermo Fisher 
Scientific. Fluorescent and HRP-conjugated secondary antibodies 
were from Molecular Probes and Jackson ImmunoResearch Labo-
ratories, respectively, and staurosporine was from Sigma-Aldrich. 
For FasL treatment, Flag-recombinant human FasL from Alexis 
was cross-linked with anti-Flag M2 from Sigma-Aldrich.
Constructs
Human Fas ΔCter (pCR3.hFasDelCter) constructs were obtained 
using the QuikChange site-directed mutagenesis kit (Invitrogen) 
with pCR3-hFas as template and using 5′-CAG ACT ATC ATC CTC 
TAG GAC ATT ACT AGT GAC TCAG-3′ and 5′-CTG AGT CAC TAG TAA 
TGT CCT AGA GGA TGA TAG TCTG-3′ oligonucleotides, and they cor-
responded with the deletion of the last 20 aa of human Fas. pCR3-
hFas, pCR3-hFasΔICD, and pCR3-hFasΔDD were kind gifts from P. 
Schneider (University of Lausanne, Epalinges, Switzerland) and 
correspond respectively with Fas full-length cDNA (FasFull), de-
leted of the entire cytoplasmic domain (FasΔICD), and deleted of 
the C-terminal domain of Fas including the death domain (DD; 
FasΔDD). Fas GFP WT was a kind gift from J. Lane (University 
of Bristol, Bristol, UK). Fas GFP ΔSLV was obtained by deleting 
the SLV tripeptide by PCR. Both GFP constructs (WT and mutant) 
were cloned in the retroviral vector LXSN. Rat Dlg1-expressing 
vector was a gift from L. Banks (International Centre for Genetic 
Engineering and Biotechnology, Trieste, Italy).
Cell Culture, treatment, transfection, and viral infection
All cell lines were grown in DMEM supplemented with 10% FBS 
supplemented with nonessential amino acids (Gibco; Thermo 
Fischer Scientific). Transient transfection of plasmids in 293T 
was obtained by using the JetPRI ME transfection reagent (Poly-
plus). For siRNA transfection, cells were transiently transfected 
using RNAiMAX lipofectamine reagent (Invitrogen) according 
to the manufacturer’s procedure. α-Catenin, E-cadherin, and 
Dlg1 silencing were obtained using individual sequences: for 
α-catenin #1, 5′-GAA GAG AGG UCG UUC UAAG-3′; and #2, 5′-GAU 
GGU AUC UUG AAG UUGA-3′; and for Dlg1 #1, 5′-CCA UAG AAC 
GGG UUA UUAA-3′; and #2, 5′-GGA AGA CAU UUA CAA CCA AGU-3′. 
E-cadherin silencing was obtained using a mix of two individual 
siRNAs (#1, 5′-GGC CUG AAG UGA CUC GUAA-3′; #2, 5′-GGG ACA 
ACG UUU AUU ACUA-3′), and siRNA targeting luciferase was used 
as control (siCtrl, 5′-CGU ACG CGG AAU ACU UCGA-3′).
Infection of HCT15 with LXSN retroviral vector expressing 
Fas GFP WT and mutant was performed as described (Gagnoux-
Palacios et al., 2005). Briefly, infectious supernatants generated 
using phoenix retroviral producer cell line supplemented with 
polybrene were added to actively growing cells at high MOI fol-
lowed by spinoculation procedure. Expressing cells were selected 
for neoresistance to geneticin (500 µg/ml; Sigma-Aldrich) 48 h 
after infection.
Preparation of FasL-coated beads
400 µl magnetic beads linked to human anti-mouse IgG (Dyna- 
beads; Invitrogen) were incubated with 40 μg M2 antibody for 
1 h at RT in DMEM and 0.1% BSA on a wheel. M2-coated beads 
were washed and incubated one more hour with 2 μg recombi-
nant FasL in the same conditions. After washing, beads were kept 
at 4°C in sterile conditions or used immediately for Fas activa-
tion. The same amount of uncoated beads was used as a control 
in these experiments.
Cell death assays
For cell death experiments, cells were incubated with indicated 
doses of recombinant human Flag-FasL (FasL) cross-linked with 1 
µg/ml M2 antibody or with FasL-coated beads. After the indicated 
incubation time at 37°C and 5% CO2, cells were collected and fixed 
in ice-cold 70% ethanol. Cells were washed in 38 mM sodium ci-
trate, pH 7.4, stained for 20 min at 37°C with 50 µg/ml propidium 
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iodide (PI; Sigma-Aldrich) and 5 µg/ml RNaseA (Sigma-Aldrich) in 
38 mM sodium citrate, and analyzed by flow cytometry using the 
Fortessa analyzer (BD). The proportion of apoptotic cells as rep-
resented by the sub-G1 peak was determined. Alternatively, cell 
death induced by FasL/M2 cotreatment or staurosporine (20 µM) 
was analyzed by video microscopy using an inverted ZEI SS Ax-
iovert200 microscope equipped with a Zeiss 10× Plan-Neofluar 
PH1 dry 0.3 NA objective lens. Images were acquired with a mono-
chrome Neo sCMOS camera (Andor Technology) controlled with 
MetaMorph 7.7 software (Molecular Devices).
IF and FasL-binding assay
For immunolabeling, cells attached to glass coverslips were fixed 
with 3.7% formaldehyde for 15 min at RT and either subsequently 
permeabilized with 0.1% Triton X-100 or incubated on ice in 
cold methanol for 5 min. After 1-h saturation in PBS contain-
ing 1% BSA and overnight incubation at 4°C with the indicated 
primary antibodies, cells were washed with PBS and incubated 
with fluorescent-conjugated secondary antibodies (Molecular 
Probes/Invitrogen) and DAPI (Sigma-Aldrich). Samples were 
analyzed using an inverted IX81 Olympus microscope (Olympus) 
equipped with a motorized XY stage (Prior Scientific), a CSU-X1 
confocal head (Yokogawa Electric Corporation), and a sensitive 
iXon DU-897-BV electron-multiplying charge-coupled device 
(EMC CD) camera (Andor Technology). Z stacks were acquired 
using a piezo stage NanoScan Z100 (Prior Scientific). The system 
was controlled using MetaMorph software. Fresh frozen sections 
of human colon were immunolabeled using a similar procedure 
and analyzed on an LSM780 confocal microscope (Zeiss) using a 
40× 1.1 NA water objective. All experimental and control images 
of the IF or phase-contrast data were collected using identical 
imaging settings, and images were merged using Fiji software 
tools (ImageJ; National Institutes of Health; Schindelin et al., 
2012). For FasL-binding assay, cells were incubated with FasL-
coated beads or uncoated beads (as a control) in DMEM and 0.1% 
BSA for 30 min at 37°C and 5% CO2. After extensive washing to 
remove unbound beads, cells were fixed with a solution of 3.7% 
formaldehyde in PBS, and phase-contrast pictures of each well 
were performed using a 10× objective. Alternatively, cells were 
lysed, and lysates were subjected to flow cytometry using the 
HTS Plate Manager (BD) to calculate the number of cell-fixed 
beads in each condition.
Specific enrichment quantification
Fas specific enrichment at cell–cell junctions or Fas and caspase 
recruitment at FasL-coated beads were quantified using the same 
the process with Fiji software. Briefly, reference regions, either 
cell–cell junctions (labeled by E-cadherin, actin, and Dlg1) or 
bead contours were defined using intensity-based thresholds. 
The intensity of the marker of interest, endogenous Fas, FasGFP, 
or cleaved caspase-8, was measured inside those predefined 
contours (cell–cell junctions or beads). Then, the intensity of the 
marker of interest, endogenous Fas, FasGFP, or cleaved caspase-8, 
was measured outside those predefined contours to measure the 
basal level of expression. Finally, the enrichment factor was cal-
culated by the ratio of the signal of interest inside/outside of the 
junctions or beads. An enrichment factor value >1 meant that the 
protein of interest was specifically enriched either in the cell–cell 
junction or at the FasL-coated beads.
DuoLink in situ PLA
To detect the interaction between Fas and Dlg1 or α-catenin, we 
used the DuoLink in situ PLA (Olink Bioscience) according to the 
manufacturer’s protocol. HCT15 or SW480 cells were seeded on 
poly-l-lysine (40 µg/ml)–coated microscope slides. Cells were 
fixed with 4% PFA and permeabilized with 0.5% Triton X-100. 
Cells were immunolabeled with primary antibodies: anti-Fas, 
anti-Dlg1, or anti–α-catenin overnight at 8°C. The secondary 
antibodies (PLA probes supplied in the DuoLink kit) were incu-
bated for 1 h at 37°C. Images were collected on an inverted Axio-
Observer Z1 microscope (Zeiss) equipped with a 63× 1.4 NA Plan 
Apochromat DIC III oil objective lens. Images were acquired with 
a monochrome EMC CD iXON+897 camera (Andor Technology) 
controlled with MetaMorph 7.8 software. A fluorescence signal 
indicated that two proteins were separated by <40 nm. PLA dots 
and nuclei were calculated in each field, and results were ex-
pressed as the mean number of count/cells.
Peptide pulldown, IP, and IB
Peptides corresponding with carboxyl terminals of human Fas 
(316–335 aa [Fas] or 316–332 aa [FasΔSLV]) were synthesized 
(GenScript) and cross-linked to NHS-activated Sepharose 4 Fast 
Flow beads according to the manufacturer’s instructions (GE 
Healthcare). Pulldown experiments were performed using HCT15 
cell lysates, and interacting proteins were identified by IB. Briefly, 
peptide-coated beads were added to cell lysates and incubated for 
2 h at 4°C. Beads were washed in lysis buffer (20 mM Hepes, pH 
7.5, 150 mM NaCl, 0.2 mM EDTA, 0.5% Triton X-100, 2 mM MgCl2, 
2 mM DTT, 10 mM NaF, 20 mM β-glycerophosphate, and a mix of 
protease inhibitors), and proteins bound to beads were separated 
by SDS-PAGE classical procedure. For IP, 293 cells transfected with 
Fas and rat Dlg1-encoding plasmids were lysed at 4°C in IP buffer: 
20 mM Hepes, pH 7.5, 150 mM NaCl, 0.2 mM EDTA, 0.5% Triton 
X-100, 10% glycerol, 2 mM MgCl2, 10 mM NaF, 20 mM β-glycero-
phosphate, and a mix of protease inhibitors. The postnuclear su-
pernatants obtained after centrifugation at 10,000 g for 10 min at 
4°C were incubated with protein G Sepharose beads (Invitrogen) 
coupled to Fas antibody (Apo1.3) for 2 h. After washes with lysis 
buffer, beads were eluted with sample buffer at 95°C for 5 min and 
subjected to SDS-PAGE and IB. To analyze DISC formation, cells 
were incubated with 20 µl FasL-coated beads at 4°C for 30 min 
to allow bead deposition and initial attachment. Cell plates were 
lysed directly (t = 0) or transferred at 37°C for various periods of 
time (from 15 to 60 min) to trigger Fas activation and DISC for-
mation before cell lysis in IP buffer. Cell lysates were sonicated, 
and protein concentration was evaluated. The same quantity of 
protein (1 mg) was used in the IP for each condition. Lysates were 
incubated for 1 h at 4°C under agitation. FasL-coated beads were 
then isolated using a magnet and washed four times with the lysis 
buffer. Magnetic beads were resuspended in Laemmli buffer, and 
protein extracts were separated by SDS-PAGE followed by classical 
IB procedures. IB analysis of total proteins was performed accord-
ing to standard protocols. Briefly, cells were lysed in 50 mM Tris, 
pH 8, 150 mM NaCl, 2 mM EDTA, 1% NP-40, 0.5% deoxycholate, 
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and 0.1% SDS containing phosphatase and protease inhibitors. 
After preclearing by centrifugation and quantification, the solubi-
lized denatured proteins were resolved by SDS-PAGE. IB was per-
formed using the indicated primary antibody and HRP-coupled 
secondary antibody (Jackson ImmunoResearch Laboratories). 
Quantitative densitometry was performed using ImageJ.
Cell surface biotinylation
The presence of Fas at the cell surface was assessed by bioti-
nylation assays followed by IP with agarose beads coupled with 
avidin according to the manufacturer’s instructions. Briefly, 
cells were washed three times in PBS, pH 8, 1 mM MgCl2, and 
0.5 mM CaCl2 at 4°C, and then sulfo-NHS-SS-biotin (Pierce) was 
added to a final concentration of 0.2 mg/ml for 30 min at 4°C. 
The monolayers were washed once in ice-cold PBS, pH 8, 1 mM 
MgCl2, and 0.5 mM CaCl2 and incubated with PBS solution con-
taining 100 mM glycine for 10 min to block free biotin. After 
incubation, cells were washed once with ice-cold PBS and lysed 
in lysis buffer. The same amount of biotinylated proteins were 
precipitated with Neutravidin-conjugated agarose (Pierce) in 
each condition for 2 h. The beads were washed three times in 
lysis buffer for 5 min each and resuspended in Laemmli buffer. 
Protein extracts were separated by SDS-PAGE followed by clas-
sical IB procedures.
Mass spectroscopy analysis
Following peptide pulldown (see above), protein extracts were 
loaded and stacked on a NuPAGE gel (Life Technologies). Stained 
bands were submitted to an in-gel trypsin digestion. Peptide ex-
tracts were reconstituted with 0.1% trifluoracetic acid in 4% ace-
tonitrile and analyzed by liquid chromatography (LC)–tandem 
mass spectrometry (MS/MS) using an Orbitrap Fusion Lumos 
Tribrid mass spectrometer (Thermo Fisher Scientific) online 
with an Ultimate 3000RSLCnano chromatography system 
(Thermo Fisher Scientific). Protein identification and quantifi-
cation were processed using the MaxQuant computational pro-
teomics platform (version 1.5.3.8) using the human subset of the 
SwissProt database (date 2018.01; 20,244 entries). The statistical 
analysis was done with Perseus program (version 1.5.6.0). Dif-
ferential proteins were detected using a two-sample t test at 0.01 
and 0.05 permutation-based false discovery rate. The mass spec-
trometry proteomics data, including search results, have been 
deposited in the ProteomeXchange Consortium via the PRI DE 
partner repository with the dataset identifier PXD009659. 
Detergent solubility assay
The detergent solubility assay was derived from Gimond et al. 
(1999). Cell cultures were lysed 20 min on ice in 300 µl of 0.5% 
Brij58, 50  mM Tris, pH 7.4, 150  mM NaCl, 1  mM EDTA, 1  mM 
EGTA, 5 mM NaF, 20 mM β-glycerophosphate, and 10 mM so-
dium pyrophosphate in the presence of protease inhibitors, 
and cell lysates were centrifuged at 14,000 rpm for 10 min to 
obtain the soluble fraction of protein. The pellet represents the 
cytoskeleton-associated protein (insoluble fraction) and was 
resuspended in 400  µl Laemmli buffer. To compare the solu-
bility of each protein, 1:15 soluble fraction (representing ∼20 
µg soluble protein) and 1:5 insoluble protein (80  µl) for each 
condition were separated in SDS-PAGE followed by classical IB 
procedures. Quantitation of protein expression was performed 
using ImageJ and was used to determine the proportion of each 
protein in soluble versus insoluble fractions. The solubility 
index for each protein represents the ratio of total amount of 
soluble versus insoluble. One representative experiment was 
shown out of three.
Statistical analysis
Data were analyzed using a homoscedastic two-tailed t 
test. P < 0.05 was considered statistically significant. *, P < 
0.05; **, P < 0.005.
Online supplemental material
Fig. S1 describes the role of the Fas C-terminal PDZ-binding site 
in the regulation of Fas detergent solubility and Fas-Dlg1 bind-
ing. Fig. S2 shows the impact of the Dlg1 polarity molecule on 
Fas detergent solubility, FasL binding, and both total and cell 
surface Fas expression. Video 1 shows the effects of FasL treat-
ment on an islet of HCT15 cells. Video  2 shows the effects of 
the treatment of the same cell line by staurosporine, a common 
chemical inducer of apoptosis. Video 3 and 4 are filmed in sim-
ilar conditions to Video  1 except that HCT15 cells were grown 
on a semipermeable cell culture or in culture media depleted 
of calcium, respectively. Table S1 shows the comprehensive 
listing of all Fas interactors identified by pulldown assay and 
LC-MS/MS analysis.
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